Naturally occurring psychedelic compounds such as DMT in ayahuasca, psilocybin in magic mushrooms, salvinorum A found in the salvia divinorum mint species, mescaline from peyote cacti and the scolpolamine…
MCUR.C
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments…
Jody speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden, to get a better idea of how the company combines psychedelic research, technology, and medicines to optimize…
Mind Cure is a life sciences company that develops and commercializes mental health and wellness products in North America. It focuses on the development of digital therapeutics tech and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
An exciting point in the markets for Psychedelics! The technicals currently indicate money returning to the psychedelics sector. Now we just look for charts that are about to breakout,…
Interest in the psychedelic market is as high as Matt Gaetz and Joel Greenberg on a night out, but the accompanying FOMO has the potential to muddy the market,…
The psychedelics space is one of the hottest investment trips in the public markets today. Embryonic, wide open to possibility and with mounting scientific evidence of psychedelics’ healing properties,…
Today Maddy speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden. Kelsey breaks down the burgeoning therapeutic world of psychedelics and outlines Mindcure’s uniquely comprehensive approach of…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…